SMN2 and proximal spinal muscular atrophy: The involvement of the UPS in SMA has also been reported previously: e.g., inhibition of UPS in patient-derived fibroblasts increases intracellular SMN levels, whereas treatment with a ubiquitination inhibitor increases SMN protein levels and slows the progression of disease in severe SMA mouse models (15, 82).